Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

DarioHealth (DRIO) Interest Expenses (2022 - 2025)

DarioHealth filings provide 3 years of Interest Expenses readings, the most recent being $1.1 million for Q4 2025.

  • On a quarterly basis, Interest Expenses changed N/A to $1.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.3 million, a N/A change, with the full-year FY2025 number at $3.0 million, changed N/A from a year prior.
  • Interest Expenses hit $1.1 million in Q4 2025 for DarioHealth, down from $1.2 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $1.2 million in Q3 2025 to a low of $788000.0 in Q3 2022.